tesaglitazar also known az dual peroxisome proliferatoractivated receptor agonist affinity pparα pparγ proposed management type drug completed several phase iii clinical however may astrazeneca announced discontinued cardiac toxicity tesaglitazar related mitochondrial toxicity caused decrease pparγ coactivator sirtuin drug article relating gastrointestinal system stub help wikipedia expanding ithttpsenwikipediaorgwikitesaglitazar